Park Hee-Young, Wu Heng, Killoran Christina E, Gilchrest Barbara A
Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA.
J Cell Sci. 2004 Jul 15;117(Pt 16):3659-68. doi: 10.1242/jcs.01219.
Protein kinase C (PKC), a family of at least eleven isoforms, mediates numerous cell functions. In human melanocytes, alpha, beta, delta, epsilon and zeta isoforms of PKC are expressed, but uniquely PKC-beta activates tyrosinase, the key and the rate-limiting enzyme in melanogenesis, by phosphorylating specific serine residues on its cytoplasmic domain. To investigate the mechanism by which only PKC-beta phosphorylates tyrosinase, we examined the expression of receptor for activated C-kinase-I (RACK-I), a receptor specific for activated PKC-beta, on the surface of melanosomes, the specialized organelle in which melanogenesis occurs. Immunoblot analysis of purified melanosomes revealed that RACK-I is readily detectable. Immunoprecipitation of RACK-I from purified melanosomes, followed by immunoblot analysis using antibody against PKC-beta, revealed abundant PKC-beta, whereas PKC-alpha was not detected when immunoblot analysis was performed using antibody against PKC-alpha. Activation of PKC in melanocytes increased the level of PKC-beta co-immunoprecipitated with RACK-I, while the level of melanosome-associated RACK-I decreased when melanocytes were treated chronically with the 12-0-tetradecanoyl-phorbol 13-Acetate (TPA), a condition known to deplete PKC and reduce tyrosinase activity. Immunoprecipitation with RACK-I antibody co-precipitated fewer PKC-beta in the presence of UV-activated 1, 1'-decamethylenebis-4-aminoquinaldinium di-iodide (DECA), known to disrupt the interaction between activated PKC-beta and RACK-I. Treatment of intact melanocytes with DECA also decreased tyrosinase activity. Moreover, suppression of RACK-I expression by transfecting melanocytes with siRNA against RACK-I reduced the basal tyrosinase activity and blocked TPA-induced increases in tyrosinase activity. Taken together, these results demonstrate that RACK-I anchors activated PKC-beta on the melanosome membrane, allowing PKC-beta to phosphorylate tyrosinase.
蛋白激酶C(PKC)是一个至少有11种亚型的家族,介导众多细胞功能。在人类黑素细胞中,PKC的α、β、δ、ε和ζ亚型均有表达,但唯有PKC-β通过磷酸化酪氨酸酶胞质结构域上的特定丝氨酸残基来激活酪氨酸酶,酪氨酸酶是黑素生成中的关键限速酶。为了研究只有PKC-β能磷酸化酪氨酸酶的机制,我们检测了活化C激酶受体I(RACK-I)的表达,RACK-I是活化PKC-β的特异性受体,位于黑素小体表面,黑素小体是发生黑素生成的特殊细胞器。对纯化的黑素小体进行免疫印迹分析显示,RACK-I易于检测到。从纯化的黑素小体中免疫沉淀RACK-I,然后用抗PKC-β抗体进行免疫印迹分析,结果显示有大量PKC-β,而用抗PKC-α抗体进行免疫印迹分析时未检测到PKC-α。黑素细胞中PKC的激活增加了与RACK-I共免疫沉淀的PKC-β水平,而当黑素细胞长期用12-0-十四烷酰佛波醇-13-乙酸酯(TPA)处理时,黑素小体相关的RACK-I水平降低,TPA这种情况已知会消耗PKC并降低酪氨酸酶活性。在紫外线激活的1,1'-癸亚甲基双-4-氨基喹哪啶二碘化物(DECA)存在的情况下,用RACK-I抗体进行免疫沉淀共沉淀的PKC-β较少,已知DECA会破坏活化的PKC-β与RACK-I之间的相互作用。用DECA处理完整的黑素细胞也会降低酪氨酸酶活性。此外,用针对RACK-I的小干扰RNA转染黑素细胞来抑制RACK-I的表达,可降低基础酪氨酸酶活性并阻断TPA诱导的酪氨酸酶活性增加。综上所述,这些结果表明RACK-I将活化的PKC-β锚定在黑素小体膜上,使PKC-β能够磷酸化酪氨酸酶。